These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 407606)

  • 21. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
    Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
    Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
    Karler R; Borys HK; Turkanis SA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):105-9. PubMed ID: 6289137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia.
    Turkanis SA; Karler R
    Life Sci; 1975 Aug; 17(4):569-78. PubMed ID: 1081172
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex.
    Revuelta AV; Moroni F; Cheney DL; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):107-10. PubMed ID: 703853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats.
    Jacobs JA; Dellarco AJ; Manfredi RA; Harclerode J
    J Pharm Pharmacol; 1979 May; 31(5):341-2. PubMed ID: 37310
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of effect of cannabinoids on carbonic anhydrase.
    Maor D; Treves T; Korczyn AD
    J Neural Transm; 1980; 49(3):205-6. PubMed ID: 6256470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
    Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
    Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A; Nazar B; Nyquist S; Harclerode J
    Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
    Hiltunen AJ; Järbe TU
    Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
    Brady KT; Balster RL
    Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
    Consroe P; Martin P; Eisenstein D
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):1-13. PubMed ID: 841172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic administration of delta-9-tetrahydrocannabinol and cannabidiol on rat testicular esterase isozymes.
    Goldstein H; Harclerode J; Nyquist SE
    Life Sci; 1977 Mar; 20(6):951-4. PubMed ID: 850463
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.
    Chiu P; Karler R; Craven C; Olsen DM; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):267-86. PubMed ID: 1197914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters.
    van Ree JM; Niesink RJ; Nir I
    Psychopharmacology (Berl); 1984; 84(4):561-5. PubMed ID: 6098915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiepileptic potential of cannabidiol analogs.
    Consroe P; Martin A; Singh V
    J Clin Pharmacol; 1981; 21(S1):428S-436S. PubMed ID: 7298873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.